Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

ASEAN Secretary-General Receives Chairman of CT Group

August 3, 2026

WeRide and GreenMobility Announce Strategic Partnership to Advance Level 4 Autonomous Mobility in Denmark, Marking WeRide’s Entry into the Nordic Region

August 3, 2026

Another batch of high-grade assays for FireFly’s resource update and economic studies

August 2, 2026

Kattitude Education Centre Limited Announces Online Expansion of Cambridge YLE Phonics Programme

August 2, 2026

MG Ship Launches AI Platform to Help Retailers and Manufacturers Gain Real-Time Supply Chain Control

August 2, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » U.S. citizen working in Congo tests positive for Ebola
Health

U.S. citizen working in Congo tests positive for Ebola

By News RoomJuly 13, 20265 Mins Read
U.S. citizen working in Congo tests positive for Ebola
Share
Facebook Twitter LinkedIn Pinterest Email

A U.S. citizen working for a humanitarian organization in the Democratic Republic of Congo (DRC) has tested positive for the Ebola virus, according to the U.S. Centers for Disease Control and Prevention (CDC).

The CDC said it was aware of a U.S. citizen who tested positive for Bundibugyo virus and that it is working with the patient’s employing organization, other U.S. federal agencies, public health authorities and partners in DRC “to help prevent further transmission by supporting contact tracing and performing risk assessments to identify high-risk contacts.”

The CDC did not provide any further details or identify the U.S. citizen who tested positive for the Bundibugyo virus,  a rare type of the Ebola virus that is behind an ongoing outbreak in the Central African country and has no approved medicines or vaccines.

The New York Times reports that the affected American worked for Samaritan’s Purse, which is a disaster relief organization.

A spokesperson for the group told the outlet that the worker has been in isolation since last Monday and is being cared for at one of two Ebola treatment centres that the organization runs in Ituri.

Global News has reached out to Samaritan’s Purse for further comment, but has not received a response.

Receive the latest medical news and health information delivered to you every Sunday.

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

Last week, the Africa Centres for Disease Control and Prevention said that the outbreak is the fastest-growing Ebola outbreak ever recorded on the continent, with 1,830 confirmed cases in Congo, including 648 deaths. Cases have also been confirmed in Uganda.

The U.S. citizen working for the humanitarian organization is the second American to contract the virus during the ongoing outbreak.

A U.S. national who tested positive for the virus in Congo arrived in Berlin in May for treatment in a special isolation ward.

“An American national who was working in DRC has also been confirmed positive, and been transferred to Germany,” WHO Director-General Tedros Adhanom Ghebreyesus said at the time.

Christian aid organization Serge confirmed one of its doctors — whom it identified as American medical missionary Dr. Peter Stafford — had been evacuated from Congo and was “receiving specialized medical treatment” after he developed Ebola symptoms.

Serge announced in May that all the organization’s workers with “potential exposure have been safely evacuated from the Democratic Republic of Congo.”

“We received confirmation that Dr. Peter Stafford safely arrived at Charite University Hospital in Germany, where he will receive the highest level of clinical care and treatment,” said Dr. Scott Myhre, Serge area director for East and Central Africa.

“The complex, coordinated efforts of many government agencies and international health authorities resulted in Peter Stafford’s safe transport and the protection of those involved in his transfer. Serge leadership extends their deepest gratitude to all involved in Peter’s care and is praying for all involved in the fight to end this ebolavirus outbreak for the good of the people of the DRC.”

Stafford, a 39-year-old board-certified general surgeon with a specialization in burn care, tested positive for Bundibugyo Ebola virus after serving patients in Bunia before the outbreak was identified.


Stafford’s 38-year-old wife, Dr. Rebekah Stafford, and their four young children, along with Dr. Patrick LaRochelle, 46, had also departed DRC for other locations, where they would be monitored in close proximity to expert care if needed, Serge said at the time.

By June 15, Stafford and his wife and their four children had arrived safely in the United States, according to the Christian aid organization.

Serge missionaries and their families who were serving in the DRC have been released from care and monitoring and have safely arrived in the U.S., the organization added.

“I am filled with gratitude to God for preserving my life, to all those who prayed on my behalf, and to the many medical providers who cared for me,” Stafford said in a statement released by Serge. “I am feeling well and thankful to be reunited with Rebekah and the kids. Our prayers continue for those in Congo who are facing this devastating epidemic and for the ongoing efforts to control the disease.”

Stafford has remained Ebola-free since May 30 and has continued to improve in health since he was released from Berlin’s Charité University Hospital in Germany.

“Our hearts remain deeply saddened for our Congolese friends and colleagues and those impacted by this outbreak. Our mission is more critical than ever as we mobilize medical support and resources to partners in the area,” said Matt Allison, Serge’s executive director.

Efforts to contain the virus have also been hampered by a funding gap, attacks on health centres and an ongoing conflict in eastern Congo, the epicentre of the outbreak.

Clinical trials for treatment began earlier this month after researchers launched a highly anticipated study in the hope of fighting the virus.

—With files from The Associated Press

&copy 2026 Global News, a division of Corus Entertainment Inc.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Some Hershey Kisses recalled in Canada due to undeclared almonds

Doctors warn of ‘exponential’ rise in serious e-scooter injuries among kids

Cyberattacks on water systems are growing in the U.S. — is Iran involved?

Are you underestimating mold-related illness? What U.S. study says

Health Canada granted injunction over unauthorized peptide retailer sales

4 out of 5 American toddler foods are ultra-processed, research says

Dr. Anthony Fauci invokes Fifth Amendment in U.S. Senate pandemic hearing

E-scooters driving ‘huge’ number of child injuries, doctors say: ‘Not toys’

Some psychiatric patients wait days in ER for hospital admission: data

Editors Picks

WeRide and GreenMobility Announce Strategic Partnership to Advance Level 4 Autonomous Mobility in Denmark, Marking WeRide’s Entry into the Nordic Region

August 3, 2026

Another batch of high-grade assays for FireFly’s resource update and economic studies

August 2, 2026

Kattitude Education Centre Limited Announces Online Expansion of Cambridge YLE Phonics Programme

August 2, 2026

MG Ship Launches AI Platform to Help Retailers and Manufacturers Gain Real-Time Supply Chain Control

August 2, 2026

Latest News

B.C. wildfires grow, put more than 5K under evacuation orders in past 24 hours

August 2, 2026

Sask. government saves human-trafficking response program in Saskatoon

August 2, 2026

Dozens protest Meta data centre planned for county north of Edmonton

August 2, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version